The current status, trends, and developments in biopharmaceutical policy making in Iran

Purpose The purpose of this study is to examine the development and current status of Iran’s biopharmaceutical industry, focusing on the evolution within the industrial, academic and policy sectors and to provide insights that may benefit other developing countries. Design/methodology/approach This study uses a qualitative exploratory-descriptive methodology. Data was collected through 18 semi-structured interviews conducted in 2021–2022 with experts from academia, industry and government in the biopharmaceutical field. Furthermore, a review of relevant documents supplemented the interviews, providing a comprehensive analysis of the growth and development of Iran’s biopharmaceutical sector. Findings This study reveals significant progress in Iran’s biopharmaceutical industry, characterized by advancements in infrastructure, institutional development and technology. Key findings include effective government policies supporting biopharmaceuticals, increased activity from private knowledge-based companies and the establishment of specialized accelerators. The sector has made notable strides in acquiring and transferring technology, enhancing networking among companies and pursuing export opportunities. Research limitations/implications The findings of this study suggest that other developing countries can learn from Iran’s approach to biopharmaceutical development. Emphasis on government support, technology transfer and the creation of supportive institutions can guide similar efforts elsewhere. The focus on networking and export strategies provides practical insights for growing biopharmaceutical sectors in other developing regions. Originality/value This research contributes to the understanding of biopharmaceutical industry development in the context of a developing country. This study highlights Iran’s unique strategies and offers a framework for other nations to consider in advancing their own biopharmaceutical sectors. This study’s insights into effective policies and practices provide valuable guidance for both policymakers and industry stakeholders.